TY - JOUR
T1 - Rhino-orbital mucormycosis
AU - Ryu, Byoung U.
AU - Laylani, Noor Adnan Rashid
AU - Davila-Siliezar, Pamela
AU - Lee, Andrew G.
N1 - Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/11/1
Y1 - 2022/11/1
N2 - Purpose of reviewThe current article will update and review the clinical and radiological manifestations and management of rhino-orbital mucormycosis (ROM).Recent findingsThere has been an increase in cases of ROM worldwide, especially in India. Immunosuppression (especially diabetes mellitus) is a known predisposing risk factor for ROM. Delayed diagnosis and treatment of ROM can be vision or life-threatening. This article reviews the clinical and radiologic features, treatment, and prognosis of ROM with special emphasis on new and emerging therapies.SummaryROM is an angioinvasive fungal infection that affects the sinuses and orbits and may present to ophthalmologists. Clinicians should have a high index of suspicion for ROM, especially in patients with poorly controlled diabetes mellitus or other immunosuppression. Corticosteroid treatment (including the recent COVID-19 pandemic) may be a predisposing risk factor for ROM.
AB - Purpose of reviewThe current article will update and review the clinical and radiological manifestations and management of rhino-orbital mucormycosis (ROM).Recent findingsThere has been an increase in cases of ROM worldwide, especially in India. Immunosuppression (especially diabetes mellitus) is a known predisposing risk factor for ROM. Delayed diagnosis and treatment of ROM can be vision or life-threatening. This article reviews the clinical and radiologic features, treatment, and prognosis of ROM with special emphasis on new and emerging therapies.SummaryROM is an angioinvasive fungal infection that affects the sinuses and orbits and may present to ophthalmologists. Clinicians should have a high index of suspicion for ROM, especially in patients with poorly controlled diabetes mellitus or other immunosuppression. Corticosteroid treatment (including the recent COVID-19 pandemic) may be a predisposing risk factor for ROM.
KW - COVID-19-associated mucormycosis
KW - orbital exenteration
KW - orbital mucormycosis
KW - rhino-orbital mucormycosis
UR - http://www.scopus.com/inward/record.url?scp=85139570650&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139570650&partnerID=8YFLogxK
U2 - 10.1097/ICU.0000000000000892
DO - 10.1097/ICU.0000000000000892
M3 - Review article
C2 - 36066372
AN - SCOPUS:85139570650
SN - 1040-8738
VL - 33
SP - 501
EP - 506
JO - Current Opinion in Ophthalmology
JF - Current Opinion in Ophthalmology
IS - 6
ER -